Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | pyruvate kinase, muscle | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus granulosus | pyruvate kinase | pyruvate kinase, muscle | 605 aa | 521 aa | 34.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | jun protein | 0.0271 | 0.7982 | 1 |
Schistosoma mansoni | single-minded | 0.0099 | 0.2235 | 0.325 |
Brugia malayi | PAS domain containing protein | 0.0099 | 0.2235 | 0.2008 |
Echinococcus multilocularis | pyruvate kinase | 0.004 | 0.0284 | 0.0355 |
Trypanosoma brucei | pyruvate kinase 1 | 0.004 | 0.0284 | 0.5 |
Giardia lamblia | Pyruvate kinase | 0.004 | 0.0284 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0271 | 0.7982 | 1 |
Trypanosoma brucei | pyruvate kinase 1, putative | 0.004 | 0.0284 | 0.5 |
Chlamydia trachomatis | pyruvate kinase | 0.004 | 0.0284 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.022 | 0.6287 | 1 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.004 | 0.0284 | 0.5 |
Plasmodium falciparum | pyruvate kinase | 0.004 | 0.0284 | 0.5 |
Toxoplasma gondii | pyruvate kinase PyK1 | 0.004 | 0.0284 | 0.5 |
Echinococcus multilocularis | jun protein | 0.0271 | 0.7982 | 1 |
Mycobacterium leprae | Probable pyruvate kinase PykA | 0.004 | 0.0284 | 0.5 |
Onchocerca volvulus | 0.0212 | 0.6039 | 1 | |
Echinococcus multilocularis | pyruvate kinase | 0.004 | 0.0284 | 0.0355 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.004 | 0.0284 | 0.5 |
Plasmodium vivax | pyruvate kinase, putative | 0.004 | 0.0284 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0263 | 0.7734 | 0.7668 |
Brugia malayi | bHLH-PAS transcription factor | 0.0073 | 0.1378 | 0.1126 |
Brugia malayi | hypoxia-induced factor 1 | 0.0305 | 0.9143 | 0.9118 |
Mycobacterium ulcerans | putative regulatory protein | 0.0073 | 0.1378 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0331 | 1 | 1 |
Echinococcus multilocularis | transfer RNA-Lys | 0.0073 | 0.1378 | 0.1726 |
Onchocerca volvulus | 0.0073 | 0.1378 | 0.1901 | |
Brugia malayi | bZIP transcription factor family protein | 0.0271 | 0.7982 | 0.7923 |
Leishmania major | pyruvate kinase | 0.004 | 0.0284 | 0.5 |
Echinococcus granulosus | single minded 2 | 0.0073 | 0.1378 | 0.1421 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.004 | 0.0284 | 0.5 |
Leishmania major | pyruvate kinase | 0.004 | 0.0284 | 0.5 |
Brugia malayi | hypothetical protein | 0.0212 | 0.6039 | 0.5924 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.004 | 0.0284 | 0.5 |
Schistosoma mansoni | jun-related protein | 0.022 | 0.6287 | 1 |
Mycobacterium tuberculosis | Probable pyruvate kinase PykA | 0.004 | 0.0284 | 0.5 |
Loa Loa (eye worm) | hypoxia-induced factor 1 | 0.0305 | 0.9143 | 0.9118 |
Schistosoma mansoni | aryl hydrocarbon receptor | 0.0099 | 0.2235 | 0.325 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0271 | 0.7982 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.1634 um | PUBCHEM_BIOASSAY: Secondary assay for Activators of Human Pyruvate Kinase M2 isoform. (Class of assay: confirmatory) [Related pubchem assays: 1634, 1631 ] | ChEMBL. | No reference |
Potency (functional) | 0.3659 uM | PUBCHEM_BIOASSAY: Confirmation Concentration-Response Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase: for Probe SAR. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.